AbbVie
ABBV
ABBV
1,955 hedge funds and large institutions have $101B invested in AbbVie in 2018 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 741 increasing their positions, 880 reducing their positions, and 94 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% less funds holding in top 10
Funds holding in top 10: 128 → 103 (-25)
27% less first-time investments, than exits
New positions opened: 69 | Existing positions closed: 94
31% less call options, than puts
Call options by funds: $897M | Put options by funds: $1.3B
Holders
1,955
Holding in Top 10
103
Calls
$897M
Puts
$1.3B
Top Buyers
| 1 | +$1.9B | |
| 2 | +$1.03B | |
| 3 | +$256M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$149M |
| 5 |
N
Natixis
Paris,
France
|
+$145M |
Top Sellers
| 1 | -$1.67B | |
| 2 | -$277M | |
| 3 | -$185M | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$169M |
| 5 |
Two Sigma Investments
New York
|
-$127M |